Devices › Device types
FDA product code MKJ · class 3 · Cardiovascular
Automated external defibrillators (non-wearable): medical device reports filed with FDA
269,686 reports carry this product code, 1992–2026; 30 brands with a page.
- 269,686
- reports with this product code
- 1% of all MAUDE reports
- 12,614
- reports, 12 months to August 2026
- 13,435 in the 12 months before
- 96.8%
- classified as malfunction
- 62.3% across all reports
- 1.7%
- classified as death, as reported
- 0.9% across all reports
Product code MKJ is FDA's classification for "Automated external defibrillators (non-wearable)" (cardiovascular panel), a class 3 device. 269,686 medical device reports carry this product code, 1% of the MAUDE database, from September 1992 to August 2026.
12,614 reports arrived in the 12 months to August 2026, close to the 13,435 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.8%), death (1.7%) and injury (0.7%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Philips Medical Systems | 88,450 | 32.8% |
| Zoll Medical | 82,926 | 30.7% |
| Physio-Control - 3015876 | 22,028 | 8.2% |
| Philips North America | 17,434 | 6.5% |
| Heartsine Technologies | 12,335 | 4.6% |
| Physio-Control | 11,975 | 4.4% |
| Cardiac Science | 7,645 | 2.8% |
| Philips Goldway Shenzhen Industrial | 7,149 | 2.7% |
| Defibtech | 5,611 | 2.1% |
| Philips Healthcare | 2,935 | 1.1% |
| Bio-Detek | 1,685 | 0.6% |
| Welch Allyn Protocol | 1,400 | 0.5% |
| Medtronic Physio-Control | 669 | 0.2% |
| Medtronic Emergency Response Systems | 506 | 0.2% |
| Agilent Technologies | 442 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Failure to power up | 34,998 | 13% |
| Device operates differently than expectedthe device behaved unexpectedly | 31,831 | 11.8% |
| Device displays incorrect message | 31,217 | 11.6% |
| Failure of device to self-test | 24,062 | 8.9% |
| Unable to obtain readings | 11,879 | 4.4% |
| No display/image | 11,373 | 4.2% |
| Defibrillation/stimulation problem | 8,703 | 3.2% |
| Self-activation or keying | 8,042 | 3% |
| Failure to charge | 6,732 | 2.5% |
| Battery problema problem with the battery | 6,718 | 2.5% |
| Device inoperablethe device could not be used | 5,101 | 1.9% |
| Electrical /electronic property probleman electrical or electronic problem | 4,996 | 1.9% |
| Unexpected shutdown | 4,969 | 1.8% |
| Detachment of device or device componentpart of the device came off | 4,910 | 1.8% |
| Failure to deliver shock/stimulation | 4,910 | 1.8% |
| Failure to discharge | 4,435 | 1.6% |
| Loss of powerthe device lost power | 4,388 | 1.6% |
| Breakthe device broke | 3,711 | 1.4% |
| Incorrect, inadequate or imprecise result or readings | 3,447 | 1.3% |
| Pacing problem | 3,157 | 1.2% |
Questions about automated external defibrillators (non-wearable) reports
What is product code MKJ?
FDA's classification code for "Automated external defibrillators (non-wearable)", class 3, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
269,686 reports through August 2026, 12,614 of them in the latest 12 months.
Which brands appear most often?
M Series (26,133), Heartstart Mrx (18,364), HeartStart MRx -EMS Defibrillator (16,151), Heart Start XL (15,937) and R Series Defibrillator (14,893). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.